Skip to content

Capecitabine

Capecitabine is an antimetabolite chemotherapy medicine used to treat metastatic breast cancer and colorectal cancer. Zocitab is the one capecitabine product listed in this catalogue.

Zocitab

Metastatic Breast Cancer, Colorectal Cancer

500mg

Capecitabine tablets for metastatic breast and colorectal cancer. The body converts it into the active chemotherapy agent inside the tumour.

From$13.62/ tabletView

Key points

  • Capecitabine is an antimetabolite, a type of chemotherapy medicine that interferes with how cells produce the genetic material they need to multiply.
  • Zocitab 500mg tablet is the only capecitabine formulation listed in this catalogue, and it is manufactured by Fresenius Kabi.
  • The medicine is taken by mouth as a tablet, which means it is swallowed whole rather than given as a liquid or injection.

Capecitabine is listed for Metastatic Breast Cancer and Colorectal Cancer. This capecitabine medicine may be part of the treatment plan for either condition and is listed in the Women’s Health category.

Further reading